Fulcrum Therapeutics (FULC) Other Non-Current Liabilities (2018 - 2026)

Fulcrum Therapeutics (FULC) has 8 years of Other Non-Current Liabilities data on file, last reported at $197000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $197000.0 in Q1 2026; TTM through Mar 2026 was $197000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $197000.0, changed 0.0% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $197000.0, roughly flat from $197000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for FULC reached as high as $447000.0 in Q2 2023 and fell as low as $197000.0 in Q2 2022.
• Historically, Other Non-Current Liabilities has averaged $220312.5 across 5 years, with a median of $197000.0 in 2022.
• Across the five-year window, Other Non-Current Liabilities soared 126.9% in 2023 and sank 55.93% in 2024, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $197000.0 in 2022, then changed by 0.0% to $197000.0 in 2023, then changed by 0.0% to $197000.0 in 2024, then changed by 0.0% to $197000.0 in 2025, then changed by 0.0% to $197000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $197000.0 in Q1 2026, $197000.0 in Q4 2025, and $197000.0 in Q3 2025.